Logo image of WHWK

WHITEHAWK THERAPEUTICS INC (WHWK) Stock Fundamental Analysis

USA - NASDAQ:WHWK - US00032Q1040 - Common Stock

2.1 USD
-0.15 (-6.67%)
Last: 11/6/2025, 8:22:28 PM
2.0788 USD
-0.02 (-1.01%)
After Hours: 11/6/2025, 8:22:28 PM
Fundamental Rating

4

Taking everything into account, WHWK scores 4 out of 10 in our fundamental rating. WHWK was compared to 534 industry peers in the Biotechnology industry. WHWK has a great financial health rating, but its profitability evaluates not so good. WHWK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

WHWK had negative earnings in the past year.
In the past year WHWK has reported a negative cash flow from operations.
WHWK had negative earnings in each of the past 5 years.
WHWK had a negative operating cash flow in each of the past 5 years.
WHWK Yearly Net Income VS EBIT VS OCF VS FCFWHWK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

WHWK's Return On Assets of -5.76% is amongst the best of the industry. WHWK outperforms 87.08% of its industry peers.
Looking at the Return On Equity, with a value of -6.05%, WHWK belongs to the top of the industry, outperforming 89.51% of the companies in the same industry.
Industry RankSector Rank
ROA -5.76%
ROE -6.05%
ROIC N/A
ROA(3y)-57.7%
ROA(5y)-50.49%
ROE(3y)-74.03%
ROE(5y)-62.56%
ROIC(3y)N/A
ROIC(5y)N/A
WHWK Yearly ROA, ROE, ROICWHWK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K

1.3 Margins

WHWK's Gross Margin of 89.10% is amongst the best of the industry. WHWK outperforms 90.45% of its industry peers.
WHWK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WHWK Yearly Profit, Operating, Gross MarginsWHWK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

8

2. Health

2.1 Basic Checks

WHWK does not have a ROIC to compare to the WACC, probably because it is not profitable.
WHWK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, WHWK has more shares outstanding
WHWK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
WHWK Yearly Shares OutstandingWHWK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
WHWK Yearly Total Debt VS Total AssetsWHWK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 4.28 indicates that WHWK is not in any danger for bankruptcy at the moment.
The Altman-Z score of WHWK (4.28) is better than 73.03% of its industry peers.
WHWK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.28
ROIC/WACCN/A
WACC8.81%
WHWK Yearly LT Debt VS Equity VS FCFWHWK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 20.41 indicates that WHWK has no problem at all paying its short term obligations.
WHWK has a better Current ratio (20.41) than 94.38% of its industry peers.
A Quick Ratio of 20.41 indicates that WHWK has no problem at all paying its short term obligations.
WHWK has a Quick ratio of 20.41. This is amongst the best in the industry. WHWK outperforms 94.38% of its industry peers.
Industry RankSector Rank
Current Ratio 20.41
Quick Ratio 20.41
WHWK Yearly Current Assets VS Current LiabilitesWHWK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.61% over the past year.
The Revenue has decreased by -9.33% in the past year.
Measured over the past years, WHWK shows a very strong growth in Revenue. The Revenue has been growing by 185.21% on average per year.
EPS 1Y (TTM)6.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.74%
Revenue 1Y (TTM)-9.33%
Revenue growth 3Y185.21%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 5.66% on average over the next years.
WHWK is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -14.87% yearly.
EPS Next Y67.01%
EPS Next 2Y14.89%
EPS Next 3Y5.66%
EPS Next 5YN/A
Revenue Next Year-72.42%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
WHWK Yearly Revenue VS EstimatesWHWK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2020 2021 2022 2023 2024 2025 2031 2032 20M 40M 60M
WHWK Yearly EPS VS EstimatesWHWK Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WHWK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WHWK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WHWK Price Earnings VS Forward Price EarningsWHWK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WHWK Per share dataWHWK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.89%
EPS Next 3Y5.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WHWK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WHITEHAWK THERAPEUTICS INC

NASDAQ:WHWK (11/6/2025, 8:22:28 PM)

After market: 2.0788 -0.02 (-1.01%)

2.1

-0.15 (-6.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-17 2026-03-17/amc
Inst Owners59.71%
Inst Owner ChangeN/A
Ins Owners12.42%
Ins Owner ChangeN/A
Market Cap98.97M
Revenue(TTM)21.60M
Net Income(TTM)-10418000
Analysts47.5
Price Target2.04 (-2.86%)
Short Float %0.56%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-114.95%
Min EPS beat(2)-251.03%
Max EPS beat(2)21.14%
EPS beat(4)2
Avg EPS beat(4)-106.76%
Min EPS beat(4)-251.03%
Max EPS beat(4)21.14%
EPS beat(8)5
Avg EPS beat(8)-47.44%
EPS beat(12)8
Avg EPS beat(12)-28.54%
EPS beat(16)10
Avg EPS beat(16)-26.56%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)118.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-347.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-81.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.58
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)-2.26
EYN/A
EPS(NY)-1.6
Fwd EYN/A
FCF(TTM)-2.05
FCFYN/A
OCF(TTM)-2.03
OCFYN/A
SpS0.46
BVpS3.65
TBVpS3.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.76%
ROE -6.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.1%
FCFM N/A
ROA(3y)-57.7%
ROA(5y)-50.49%
ROE(3y)-74.03%
ROE(5y)-62.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 554.49%
Cap/Sales 4.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 20.41
Quick Ratio 20.41
Altman-Z 4.28
F-Score4
WACC8.81%
ROIC/WACCN/A
Cap/Depr(3y)1160.76%
Cap/Depr(5y)712.22%
Cap/Sales(3y)8.52%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.74%
EPS Next Y67.01%
EPS Next 2Y14.89%
EPS Next 3Y5.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.33%
Revenue growth 3Y185.21%
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-72.42%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y-41.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.99%
OCF growth 3YN/A
OCF growth 5YN/A

WHITEHAWK THERAPEUTICS INC / WHWK FAQ

What is the fundamental rating for WHWK stock?

ChartMill assigns a fundamental rating of 4 / 10 to WHWK.


Can you provide the valuation status for WHITEHAWK THERAPEUTICS INC?

ChartMill assigns a valuation rating of 0 / 10 to WHITEHAWK THERAPEUTICS INC (WHWK). This can be considered as Overvalued.


How profitable is WHITEHAWK THERAPEUTICS INC (WHWK) stock?

WHITEHAWK THERAPEUTICS INC (WHWK) has a profitability rating of 2 / 10.


What is the earnings growth outlook for WHITEHAWK THERAPEUTICS INC?

The Earnings per Share (EPS) of WHITEHAWK THERAPEUTICS INC (WHWK) is expected to grow by 67.01% in the next year.


Is the dividend of WHITEHAWK THERAPEUTICS INC sustainable?

The dividend rating of WHITEHAWK THERAPEUTICS INC (WHWK) is 0 / 10 and the dividend payout ratio is 0%.